Alder BioPharmaceuticals Inc (ALDR)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

11804 NORTH CREEK PARKWAY SOUTH BOTHELL, WA 98011

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company offers identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

Data based on most recent fiscal year report
Market Cap858.176 Million Shares Outstanding67.84 Million Avg Volume1.94 Million
1-Yr BETA vs S&P TR Current Ratio12.29 Quick Ratio12.29
View SEC Filings from ALDR instead.

View recent insider trading info

Funds Holding ALDR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALDR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
4,824,883 2020-04-03 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
4,041,211 2020-03-27 0

CAMPOY CARLOS CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-23 1

SANDOVAL ELISABETH

  • Director
0 2020-03-19 0

H LUNDBECK A S

  • 10% Owner
522,499 2020-03-16 2

PRESTON HEATHER

  • Director
5,450 2020-03-10 1

SIEGALL CLAY B PRESIDENT AND CEO

  • Officer
  • Director
758,784 2020-03-09 2

AZELBY ROBERT

  • Director
0 2020-02-26 2

YARNO WENDY L

  • Director
0 2019-12-17 2

NOVO HOLDINGS A/S

  • 10% Owner
  • SEE REMARKS
2,434,470 2019-11-25 0

SMITH JEFFREY T L MANAGING DIRECTOR

  • Officer
0 2019-10-22 3

MONTGOMERY ALAN BRUCE

  • Director
0 2019-10-22 2

HASSLER RANDAL EVP, PHARMACEUTICAL OPS.

  • Officer
0 2019-10-22 2

CLEVELAND PAUL B

  • Director
0 2019-10-22 2

CARTER PAUL RUTHERFORD

  • Director
0 2019-10-22 2

BUCHER JAMES B EVP & GENERAL COUNSEL

  • Officer
0 2019-10-22 2

LAVELLE ERIN CHIEF OPERATING OFFICER

  • Officer
0 2019-10-22 2

STRECK PAUL CHIEF MEDICAL OFFICER

  • Officer
0 2019-10-22 1

DAC NADIA CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-10-22 1

CARTER ERIC G

  • Director
0 2019-07-31 0

PAKIANATHAN DEEPIKA

  • Director
0 2019-06-06 0

BENEDICT LARRY EVP AND PAO

  • Officer
39,728 2019-04-23 1

BRIDGER GARY

  • Director
0 2019-03-13 0

LITTON MARK JAMES SEE REMARKS

  • Officer
0 2019-02-06 0

LATHAM JOHN A CHIEF SCIENTIFIC OFFICER

  • Officer
244,180 2019-02-06 0

BISGAARD PETER

  • Director
0 2018-06-28 0

SCHATZMAN RANDALL C PRESIDENT AND CEO

  • Officer
  • Director
0 2018-02-16 0

DOW STEPHEN M

  • Director
307,190 2017-07-18 0

WHITAKER TIMOTHY M CHIEF MEDICAL OFFICER

  • Officer
0 2017-01-27 0

SRB ASSOCIATES IX L.P.

SEVIN ROSEN FUND IX L.P.

SEVIN ROSEN IX AFFILIATES FUND L.P.

  • AFFILIATEAFFILIATEAFFILIATE
No longer subject to file 2015-08-31 0

JAGGERS JOHN V

BAYLESS JON W

DOMENIK STEPHEN L

KIMZEY JACKIE R

MCLEAN DAVID J.

OXAAL JOHN T

SCHUELE ALAN R

STURIALE NICHOLAS G

  • AFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATE
1,849,885 2015-08-11 0

DAVIDSON AARON

  • Director
2,581,976 2014-05-13 0

H.I.G. VENTURE PARTNERS II, L.P.

H.I.G. VENTURES - ALDER, LLC

  • 10% Owner
516,395 2014-05-13 0

DELPHI MANAGEMENT PARTNERS VII, L.L.C.

DELPHI VENTURES VII L P

DELPHI BIOINVESTMENTS VII LP

PAKIANATHAN DEEPIKA

ROEDER DOUGLAS A

DOUGLASS DAVID L

BOCHNOWSKI JAMES J

  • Director
  • 10% Owner
2,838,532 2014-05-13 0

VENTURES WEST 8 LIMITED PARTNERSHIP

  • 10% Owner
3,469,528 2014-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments